LABORATORY CORPORATION OF AMERICA HOLDINGS

Laboratory Corporation of America Holdings

Equities

LH

US50540R4092

Healthcare Facilities & Services

Market Closed - Nyse Other stock markets 04:00:01 2024-04-24 pm EDT			5-day change	1st Jan Change
207.9 ^USD	-0.01%		+3.99%	-8.51%

12:59pm	Labcorp beats quarterly estimates on strong testing demand	RE
12:07pm	North American Morning Briefing : More Tech -2-	DJ

Laboratory Corporation of America Holdings (NYSE:LH) completed the acquisition of Ovia Health Inc.

August 11, 2021

Laboratory Corporation of America Holdings (NYSE:LH) accquired Ovia Health Inc. on August 12, 2021. Ovia has clocked about $20 million in annual revenue. Kilpatrick Townsend & Stockton LLP acted as legal advisor to Laboratory Corporation of America Holdings. Raymond James & Associates, Inc. acted as financial advisor to Ovia Health Inc. Alexander J. Aber, Earl W. Mellott, Christopher T. Natkanski and Ellie Kang of Foley Hoag LLP acted as legal advisor to Ovia Health Inc. Laboratory Corporation of America Holdings (NYSE:LH) completed the acquisition of Ovia Health Inc. on August 12, 2021.

Latest news about Laboratory Corporation of America Holdings

Labcorp beats quarterly estimates on strong testing demand	06:59am	RE
North American Morning Briefing : More Tech -2-	06:07am	DJ
Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln	10:23pm	RE
Laboratory Corporation of America Holdings (NYSE:LH) won the bid to acquire substantially all of the assets of Invitae Corporation for approximately $240 million.	Apr. 23	CI
Laboratory Corporation of America Holdings (NYSE:LH) agreed to acquire Substantially all Assets of Invitae Corporation for approximately $240 million.	Apr. 23	CI
Labcorp Introduces Test for Early Detection of Neurodegenerative Diseases	Apr. 15	MT
Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw	Apr. 15	CI
Labcorp Keeps Quarterly Dividend at $0.72 Per Share, Payable June 12 to Stockholders of Record May 28	Apr. 11	MT
Labcorp Declares Quarterly Dividend, Payable on June 12, 2024	Apr. 11	CI
Sector Update: Health Care Stocks Slump Wednesday Afternoon	Apr. 10	MT
Labcorp Says US FDA Granted Emergency Use Authorization for Mpox Home Collection Kit	Apr. 10	MT
Labcorp Gets Emergency Authorization from FDA for Home Kit to Detect Monkeypox	Apr. 10	DJ
Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit	Apr. 10	CI
Laboratory Corp of America Expands Precision Oncology Portfolio	Apr. 08	MT
Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs	Apr. 08	CI
Labcorp Launches Labcorp Plasma Detect? Extending Leadership into Molecular Residual Disease Clinical Research	Apr. 05	CI
Laboratory Corporation Receives a Shareholder Proposal from People for the Ethical Treatment of Animals	Apr. 04	CI
Laboratory Corporation Receives a Shareholder Proposal from Tara Health Foundation	Apr. 04	CI
Laboratory Corporation Receives a Shareholder Proposal from John Chevedden	Apr. 04	CI
Laboratory Corp Of America Holdings Insider Sold Shares Worth $760,515, According to a Recent SEC Filing	Apr. 03	MT
Laboratory Corp Of America Holdings Insider Sold Shares Worth $1,407,387, According to a Recent SEC Filing	Apr. 03	MT
Labcorp to Present Diverse Portfolio of Precision Oncology Research at the Annual Meeting of the American Association for Cancer Research	Apr. 02	CI
Labcorp Expands Investment, Collaboration Pact with Xcell Biosciences	Apr. 01	MT
Xcell Biosciences Strengthens Cell and Gene Therapy Collaboration with Labcorp	Apr. 01	CI
Prelude Network Announces Expansion of Partnership with Labcorp to Serve as Its Preferred Genetic Carrier Screening Lab	Mar. 29	CI

Chart Laboratory Corporation of America Holdings

Duration

Period

Chart Laboratory Corporation of America Holdings

More charts

Company Profile

Laboratory Corporation of America Holdings is the No. 2 clinical laboratory in the United States. Net sales (including intragroup) break down by activity as follows: - clinical laboratory services (63.9%): routine testing, patient diagnosis, disease monitoring and treatment, and other services; - development and clinical trial services (36.1%): for pharmaceutical, biotechnology, medical device and diagnostic companies. Net sales are distributed geographically as follows : North America (81.2%), Europe (12.7%) and other (6.1%).

Sector

Healthcare Facilities & Services

Calendar

2024-04-24 - Q1 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Laboratory Corporation of America Holdings

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

207.9 USD

Average target price

243.8 USD

Spread / Average Target

+17.25%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
LABORATORY CORPORATION OF AMERICA HOLDINGS	-8.51%	17.49B
CVS HEALTH CORPORATION	-14.17%	85.42B
HCA HEALTHCARE, INC.	+17.86%	84.38B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+10.92%	29.39B
FRESENIUS SE & CO. KGAA	-2.64%	16.44B
QUEST DIAGNOSTICS INCORPORATED	-0.24%	15.28B
EUROFINS SCIENTIFIC SE	-1.83%	11.71B
FRESENIUS MEDICAL CARE AG	+0.55%	12.22B
PURE HEALTH HOLDING	-31.23%	11.98B
DAVITA INC.	+26.71%	11.64B

Other Healthcare Facilities & Services